Loading…

Treatment with the anti-tumor drugs, cis-platin and mafosfamide, does not affect the structure of prekinetochores in a human breast cancer cell line. An immunofluorescence study using human anti-centromere autoantibodies

The goal of the present article was to determine whether a nuclear parameter, centromere structure of interphase cells, could serve as an indicator to assess cellular damage caused by anti-tumor drugs. These were cis-platin and mafosfamide, which are widely used for the management of solid tumors. T...

Full description

Saved in:
Bibliographic Details
Published in:Annals of anatomy 1996-10, Vol.178 (5), p.425
Main Authors: Wolf, K W, Mentzel, M, Mendoza, A S
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 5
container_start_page 425
container_title Annals of anatomy
container_volume 178
creator Wolf, K W
Mentzel, M
Mendoza, A S
description The goal of the present article was to determine whether a nuclear parameter, centromere structure of interphase cells, could serve as an indicator to assess cellular damage caused by anti-tumor drugs. These were cis-platin and mafosfamide, which are widely used for the management of solid tumors. To visualize the centromeres, we probed treated and untreated cells of a human breast cancer cell line, MX-1, with a human anti-centromere serum. The serum was obtained from a scleroderma patient and detects antigens associated with prekinetochores of the decondensed chromosomes. The DNA was simultaneously displayed by a specific fluorescent dye. The cells were grown on coverslips, incubated for 1 h in a drug-containing medium, transferred into a drug-free medium and observed 24 h later. Since the efficiency of many anti-tumor drugs increases with the temperature, two different temperatures, 37 and 42 degrees C, were used. The analysis revealed that the treatment did not visibly alter the labeling pattern. We conclude that chromosome structure remains largely intact and is not suitable for the cytological evaluation of the efficiency of anti-tumor drugs. This is in contrast with, for example, the microtubular cytoskeleton and mitochondria, which were extensively damaged under the conditions applied here (compare Wolf et al. 1995). Independent of the drug and the temperature selected, the nuclear lumen of mononucleated and multinucleated cells contained small fluorescent spots. Double dots corresponding to the sister centromeres in the G2 phase of the cell cycle were rare. In addition to the voluminous nuclei, some cells possessed micronuclei in the lateral cytoplasm and these were regularly labeled by the autoantibodies. A small subset of the mononucleated MX-1 cells had unusually large nuclei. It is reasonable to assume that they are polyploid. The fluorescent spots marking the prekinetochores were very large in these cells. This may indicate that the chromosomes remain associated after replication.
doi_str_mv 10.1016/S0940-9602(96)80132-4
format article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_8931853</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>8931853</sourcerecordid><originalsourceid>FETCH-LOGICAL-p121t-7e57d5ce7fab0ac0c520a63f31c4f476a9b1194fd1a1eaf6fd69535aa0e0f3a03</originalsourceid><addsrcrecordid>eNo9kE9rGzEQxXVocJ2kH8EwxxayqWTtyt5jCGlTCPRQ92xmpZGtdiUt-kPId82H6To1OQ289-b3hmFsJfit4EJ9_cX7lje94uvPvfqy5UKum_YDW77LH9llzn84l6pT7YIttr0U204u2esuERZPocCzK0coRwIMxTWl-pjApHrIN6BdbqYRiwuzacCjjdmid4ZuwETKEGIBtJZ0eSPkkqouNRFEC1Oivy5QifoY05w9QeBYPQYY5vJcQGPQlEDTOMI4R2_hLoDzvoZox3pa0jQnZmw1L1CzC4cz4O3U2SwpeprrsJZ40oZoHOVrdmFxzPTpPK_Y728Pu_vH5unn9x_3d0_NJNaiNBvqNqbTtLE4cNRcd2uOSlopdGvbjcJ-EKJvrREoCK2yRvWd7BA5cSuRyyu2-s-d6uDJ7KfkPKaX_fnL8h-fuYWT</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Treatment with the anti-tumor drugs, cis-platin and mafosfamide, does not affect the structure of prekinetochores in a human breast cancer cell line. An immunofluorescence study using human anti-centromere autoantibodies</title><source>ScienceDirect Freedom Collection</source><creator>Wolf, K W ; Mentzel, M ; Mendoza, A S</creator><creatorcontrib>Wolf, K W ; Mentzel, M ; Mendoza, A S</creatorcontrib><description>The goal of the present article was to determine whether a nuclear parameter, centromere structure of interphase cells, could serve as an indicator to assess cellular damage caused by anti-tumor drugs. These were cis-platin and mafosfamide, which are widely used for the management of solid tumors. To visualize the centromeres, we probed treated and untreated cells of a human breast cancer cell line, MX-1, with a human anti-centromere serum. The serum was obtained from a scleroderma patient and detects antigens associated with prekinetochores of the decondensed chromosomes. The DNA was simultaneously displayed by a specific fluorescent dye. The cells were grown on coverslips, incubated for 1 h in a drug-containing medium, transferred into a drug-free medium and observed 24 h later. Since the efficiency of many anti-tumor drugs increases with the temperature, two different temperatures, 37 and 42 degrees C, were used. The analysis revealed that the treatment did not visibly alter the labeling pattern. We conclude that chromosome structure remains largely intact and is not suitable for the cytological evaluation of the efficiency of anti-tumor drugs. This is in contrast with, for example, the microtubular cytoskeleton and mitochondria, which were extensively damaged under the conditions applied here (compare Wolf et al. 1995). Independent of the drug and the temperature selected, the nuclear lumen of mononucleated and multinucleated cells contained small fluorescent spots. Double dots corresponding to the sister centromeres in the G2 phase of the cell cycle were rare. In addition to the voluminous nuclei, some cells possessed micronuclei in the lateral cytoplasm and these were regularly labeled by the autoantibodies. A small subset of the mononucleated MX-1 cells had unusually large nuclei. It is reasonable to assume that they are polyploid. The fluorescent spots marking the prekinetochores were very large in these cells. This may indicate that the chromosomes remain associated after replication.</description><identifier>ISSN: 0940-9602</identifier><identifier>DOI: 10.1016/S0940-9602(96)80132-4</identifier><identifier>PMID: 8931853</identifier><language>eng</language><publisher>Germany</publisher><subject>Antineoplastic Agents - pharmacology ; Breast Neoplasms - pathology ; Centromere - drug effects ; Centromere - ultrastructure ; Cisplatin - pharmacology ; Cyclophosphamide - analogs &amp; derivatives ; Cyclophosphamide - pharmacology ; Fluorescent Antibody Technique, Indirect ; Humans ; Kinetochores - drug effects ; Micronuclei, Chromosome-Defective - drug effects ; Microscopy, Electron ; Temperature ; Tumor Cells, Cultured</subject><ispartof>Annals of anatomy, 1996-10, Vol.178 (5), p.425</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8931853$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wolf, K W</creatorcontrib><creatorcontrib>Mentzel, M</creatorcontrib><creatorcontrib>Mendoza, A S</creatorcontrib><title>Treatment with the anti-tumor drugs, cis-platin and mafosfamide, does not affect the structure of prekinetochores in a human breast cancer cell line. An immunofluorescence study using human anti-centromere autoantibodies</title><title>Annals of anatomy</title><addtitle>Ann Anat</addtitle><description>The goal of the present article was to determine whether a nuclear parameter, centromere structure of interphase cells, could serve as an indicator to assess cellular damage caused by anti-tumor drugs. These were cis-platin and mafosfamide, which are widely used for the management of solid tumors. To visualize the centromeres, we probed treated and untreated cells of a human breast cancer cell line, MX-1, with a human anti-centromere serum. The serum was obtained from a scleroderma patient and detects antigens associated with prekinetochores of the decondensed chromosomes. The DNA was simultaneously displayed by a specific fluorescent dye. The cells were grown on coverslips, incubated for 1 h in a drug-containing medium, transferred into a drug-free medium and observed 24 h later. Since the efficiency of many anti-tumor drugs increases with the temperature, two different temperatures, 37 and 42 degrees C, were used. The analysis revealed that the treatment did not visibly alter the labeling pattern. We conclude that chromosome structure remains largely intact and is not suitable for the cytological evaluation of the efficiency of anti-tumor drugs. This is in contrast with, for example, the microtubular cytoskeleton and mitochondria, which were extensively damaged under the conditions applied here (compare Wolf et al. 1995). Independent of the drug and the temperature selected, the nuclear lumen of mononucleated and multinucleated cells contained small fluorescent spots. Double dots corresponding to the sister centromeres in the G2 phase of the cell cycle were rare. In addition to the voluminous nuclei, some cells possessed micronuclei in the lateral cytoplasm and these were regularly labeled by the autoantibodies. A small subset of the mononucleated MX-1 cells had unusually large nuclei. It is reasonable to assume that they are polyploid. The fluorescent spots marking the prekinetochores were very large in these cells. This may indicate that the chromosomes remain associated after replication.</description><subject>Antineoplastic Agents - pharmacology</subject><subject>Breast Neoplasms - pathology</subject><subject>Centromere - drug effects</subject><subject>Centromere - ultrastructure</subject><subject>Cisplatin - pharmacology</subject><subject>Cyclophosphamide - analogs &amp; derivatives</subject><subject>Cyclophosphamide - pharmacology</subject><subject>Fluorescent Antibody Technique, Indirect</subject><subject>Humans</subject><subject>Kinetochores - drug effects</subject><subject>Micronuclei, Chromosome-Defective - drug effects</subject><subject>Microscopy, Electron</subject><subject>Temperature</subject><subject>Tumor Cells, Cultured</subject><issn>0940-9602</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><recordid>eNo9kE9rGzEQxXVocJ2kH8EwxxayqWTtyt5jCGlTCPRQ92xmpZGtdiUt-kPId82H6To1OQ289-b3hmFsJfit4EJ9_cX7lje94uvPvfqy5UKum_YDW77LH9llzn84l6pT7YIttr0U204u2esuERZPocCzK0coRwIMxTWl-pjApHrIN6BdbqYRiwuzacCjjdmid4ZuwETKEGIBtJZ0eSPkkqouNRFEC1Oivy5QifoY05w9QeBYPQYY5vJcQGPQlEDTOMI4R2_hLoDzvoZox3pa0jQnZmw1L1CzC4cz4O3U2SwpeprrsJZ40oZoHOVrdmFxzPTpPK_Y728Pu_vH5unn9x_3d0_NJNaiNBvqNqbTtLE4cNRcd2uOSlopdGvbjcJ-EKJvrREoCK2yRvWd7BA5cSuRyyu2-s-d6uDJ7KfkPKaX_fnL8h-fuYWT</recordid><startdate>199610</startdate><enddate>199610</enddate><creator>Wolf, K W</creator><creator>Mentzel, M</creator><creator>Mendoza, A S</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>199610</creationdate><title>Treatment with the anti-tumor drugs, cis-platin and mafosfamide, does not affect the structure of prekinetochores in a human breast cancer cell line. An immunofluorescence study using human anti-centromere autoantibodies</title><author>Wolf, K W ; Mentzel, M ; Mendoza, A S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p121t-7e57d5ce7fab0ac0c520a63f31c4f476a9b1194fd1a1eaf6fd69535aa0e0f3a03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Antineoplastic Agents - pharmacology</topic><topic>Breast Neoplasms - pathology</topic><topic>Centromere - drug effects</topic><topic>Centromere - ultrastructure</topic><topic>Cisplatin - pharmacology</topic><topic>Cyclophosphamide - analogs &amp; derivatives</topic><topic>Cyclophosphamide - pharmacology</topic><topic>Fluorescent Antibody Technique, Indirect</topic><topic>Humans</topic><topic>Kinetochores - drug effects</topic><topic>Micronuclei, Chromosome-Defective - drug effects</topic><topic>Microscopy, Electron</topic><topic>Temperature</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wolf, K W</creatorcontrib><creatorcontrib>Mentzel, M</creatorcontrib><creatorcontrib>Mendoza, A S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Annals of anatomy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wolf, K W</au><au>Mentzel, M</au><au>Mendoza, A S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment with the anti-tumor drugs, cis-platin and mafosfamide, does not affect the structure of prekinetochores in a human breast cancer cell line. An immunofluorescence study using human anti-centromere autoantibodies</atitle><jtitle>Annals of anatomy</jtitle><addtitle>Ann Anat</addtitle><date>1996-10</date><risdate>1996</risdate><volume>178</volume><issue>5</issue><spage>425</spage><pages>425-</pages><issn>0940-9602</issn><abstract>The goal of the present article was to determine whether a nuclear parameter, centromere structure of interphase cells, could serve as an indicator to assess cellular damage caused by anti-tumor drugs. These were cis-platin and mafosfamide, which are widely used for the management of solid tumors. To visualize the centromeres, we probed treated and untreated cells of a human breast cancer cell line, MX-1, with a human anti-centromere serum. The serum was obtained from a scleroderma patient and detects antigens associated with prekinetochores of the decondensed chromosomes. The DNA was simultaneously displayed by a specific fluorescent dye. The cells were grown on coverslips, incubated for 1 h in a drug-containing medium, transferred into a drug-free medium and observed 24 h later. Since the efficiency of many anti-tumor drugs increases with the temperature, two different temperatures, 37 and 42 degrees C, were used. The analysis revealed that the treatment did not visibly alter the labeling pattern. We conclude that chromosome structure remains largely intact and is not suitable for the cytological evaluation of the efficiency of anti-tumor drugs. This is in contrast with, for example, the microtubular cytoskeleton and mitochondria, which were extensively damaged under the conditions applied here (compare Wolf et al. 1995). Independent of the drug and the temperature selected, the nuclear lumen of mononucleated and multinucleated cells contained small fluorescent spots. Double dots corresponding to the sister centromeres in the G2 phase of the cell cycle were rare. In addition to the voluminous nuclei, some cells possessed micronuclei in the lateral cytoplasm and these were regularly labeled by the autoantibodies. A small subset of the mononucleated MX-1 cells had unusually large nuclei. It is reasonable to assume that they are polyploid. The fluorescent spots marking the prekinetochores were very large in these cells. This may indicate that the chromosomes remain associated after replication.</abstract><cop>Germany</cop><pmid>8931853</pmid><doi>10.1016/S0940-9602(96)80132-4</doi></addata></record>
fulltext fulltext
identifier ISSN: 0940-9602
ispartof Annals of anatomy, 1996-10, Vol.178 (5), p.425
issn 0940-9602
language eng
recordid cdi_pubmed_primary_8931853
source ScienceDirect Freedom Collection
subjects Antineoplastic Agents - pharmacology
Breast Neoplasms - pathology
Centromere - drug effects
Centromere - ultrastructure
Cisplatin - pharmacology
Cyclophosphamide - analogs & derivatives
Cyclophosphamide - pharmacology
Fluorescent Antibody Technique, Indirect
Humans
Kinetochores - drug effects
Micronuclei, Chromosome-Defective - drug effects
Microscopy, Electron
Temperature
Tumor Cells, Cultured
title Treatment with the anti-tumor drugs, cis-platin and mafosfamide, does not affect the structure of prekinetochores in a human breast cancer cell line. An immunofluorescence study using human anti-centromere autoantibodies
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T08%3A05%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20with%20the%20anti-tumor%20drugs,%20cis-platin%20and%20mafosfamide,%20does%20not%20affect%20the%20structure%20of%20prekinetochores%20in%20a%20human%20breast%20cancer%20cell%20line.%20An%20immunofluorescence%20study%20using%20human%20anti-centromere%20autoantibodies&rft.jtitle=Annals%20of%20anatomy&rft.au=Wolf,%20K%20W&rft.date=1996-10&rft.volume=178&rft.issue=5&rft.spage=425&rft.pages=425-&rft.issn=0940-9602&rft_id=info:doi/10.1016/S0940-9602(96)80132-4&rft_dat=%3Cpubmed%3E8931853%3C/pubmed%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p121t-7e57d5ce7fab0ac0c520a63f31c4f476a9b1194fd1a1eaf6fd69535aa0e0f3a03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/8931853&rfr_iscdi=true